ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
96,139.74
-1.10%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aethlon Medical Inc (AEMD)

  7. Aethlon Medical Inc (AEMD) News

AEMD

Aethlon Medical (AEMD)

Aethlon Medical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AEMD
DateTimeSourceHeadlineSymbolCompany
12/20/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
12/20/20247:01AMPR Newswire (US)Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird FluNASDAQ:AEMDAethlon Medical Inc
11/15/20243:40PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AEMDAethlon Medical Inc
11/13/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
11/13/20243:15PMPR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
11/12/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
11/11/20247:01AMPR Newswire (US)Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in AustraliaNASDAQ:AEMDAethlon Medical Inc
11/06/20247:01AMPR Newswire (US)Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024NASDAQ:AEMDAethlon Medical Inc
10/08/20247:01AMPR Newswire (US)Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:AEMDAethlon Medical Inc
10/03/20243:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
10/02/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
10/01/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
10/01/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
10/01/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
09/19/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
09/19/20247:01AMPR Newswire (US)Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in IndiaNASDAQ:AEMDAethlon Medical Inc
09/16/20247:01AMPR Newswire (US)Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
09/13/20247:35AMGlobeNewswire Inc.Aethlon Medical to Present at the Life Sciences Investor Forum September 19thNASDAQ:AEMDAethlon Medical Inc
08/27/20247:01AMPR Newswire (US)Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor KidneysNASDAQ:AEMDAethlon Medical Inc
08/15/20243:34PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AEMDAethlon Medical Inc
08/15/20243:32PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AEMDAethlon Medical Inc
08/15/20243:30PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AEMDAethlon Medical Inc
08/15/20243:15PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:AEMDAethlon Medical Inc
08/14/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
08/14/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
08/14/20243:15PMPR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
08/12/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
08/12/20247:01AMPR Newswire (US)Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
08/06/20248:12AMPR Newswire (US)Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024NASDAQ:AEMDAethlon Medical Inc
06/27/20243:15PMPR Newswire (US)Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
 Showing the most relevant articles for your search:NASDAQ:AEMD

Your Recent History

NASDAQ
AEMD
Aethlon Medical
BINA
DOTBRL
Polkadot
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads